VEGFR2 pY949 signalling regulates adherens junction integrity and metastatic spread

Nature Communications

Volumn 7, Issue , 2016, Pages

  Li, Xiujuan ^a   Padhan, Narendra ^a   Sjöström, Elisabet O ^a   Roche, Francis P ^a   Testini, Chiara ^a   Honkura, Naoki ^a   Sáinz Jaspeado, Miguel ^a   Gordon, Emma ^a   Bentley, Katie ^a,b   Philippides, Andrew ^c   Tolmachev, Vladimir ^a   Dejana, Elisabetta ^a,d   Stan, Radu V ^e   Vestweber, Dietmar ^f   Ballmer Hofer, Kurt ^g   Betsholtz, Christer ^a,h   Pietras, Kristian ⁱ   Jansson, Leif ^j   Claesson Welsh, Lena ^a  

^a UPPSALA UNIVERSITY   (Sweden)

^b HARVARD MEDICAL SCHOOL   (United States)

^c UNIVERSITY OF SUSSEX   (United Kingdom)

^d FIRC INSTITUTE OF MOLECULAR ONCOLOGY   (Italy)

^e DARTMOUTH MEDICAL SCHOOL   (United States)

^f MAX PLANCK INSTITUTE FOR MOLECULAR BIOMEDICINE   (Germany)

^g PAUL SCHERRER INSTITUTE   (Switzerland)

^h KAROLINSKA INSTITUTE   (Sweden)

ⁱ LUND UNIVERSITY   (Sweden)

^j UPPSALA UNIVERSITY   (Sweden)

more..

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; TEMOZOLOMIDE; VASCULAR ENDOTHELIAL CADHERIN; VASCULOTROPIN RECEPTOR; CADHERIN; LEUKOCYTE ANTIGEN; MICROSPHERE; PROTEIN KINASE P60; VASCULOTROPIN A; VASCULOTROPIN RECEPTOR 2; VEGFR2 PROTEIN, MOUSE;

BIOACTIVITY; CANCER; CHEMOTHERAPY; PATHOLOGY; PHYSIOLOGY; RODENT; TUMOR;

ADULT; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLOOD BRAIN BARRIER; BLOOD FLOW; BLOOD PRESSURE; BLOOD VESSEL PERMEABILITY; CANCER CHEMOTHERAPY; CANCER GROWTH; CELL JUNCTION; COMPARATIVE STUDY; CONTROLLED STUDY; EDEMA; EMBRYO; ENDOCRINE TUMOR; ENDOTHELIUM; FEMALE; GLIOBLASTOMA; IN VIVO STUDY; MALE; METASTASIS; MOUSE; MOUSE MUTANT; NONHUMAN; ONCOGENE SRC; PROTEIN PHOSPHORYLATION; REGULATORY MECHANISM; SIGNAL TRANSDUCTION; TUMOR MICROENVIRONMENT; TUMOR VASCULARIZATION; ADHERENS JUNCTION; ANIMAL; CANCER TRANSPLANTATION; CAPILLARY PERMEABILITY; ENDOTHELIUM CELL; EXPERIMENTAL MELANOMA; GENETICS; GLIOMA; METABOLISM; MUTATION; PATHOLOGY; PHOSPHORYLATION; VASCULAR ENDOTHELIUM;

MUS;

ADHERENS JUNCTIONS; ANIMALS; ANTIGENS, CD; CADHERINS; CAPILLARY PERMEABILITY; EDEMA; ENDOTHELIAL CELLS; ENDOTHELIUM, VASCULAR; GLIOMA; MELANOMA, EXPERIMENTAL; MICE; MICROSPHERES; MUTATION; NEOPLASM METASTASIS; NEOPLASM TRANSPLANTATION; PHOSPHORYLATION; PROTO-ONCOGENE PROTEINS PP60(C-SRC); SIGNAL TRANSDUCTION; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR-2;

EID: 84962295137     PISSN: None     EISSN: 20411723     Source Type: Journal    
DOI: 10.1038/ncomms11017     Document Type: Article

References (48)

1. Baluk, P., Hashizume, H. & McDonald, D. M. Cellular abnormalities of blood vessels as targets in cancer. Curr. Opin. Genet. Dev. 15, 102-111 (2005).
2. Liao, D. & Johnson, R. S. Hypoxia: a key regulator of angiogenesis in cancer. Cancer Metastasis Rev. 26, 281-290 (2007).
3. Dejana, E., Orsenigo, F. & Lampugnani, M. G. The role of adherens junctions and VE-cadherin in the control of vascular permeability. J. Cell Sci. 121, 2115-2122 (2008).
4. Goel, S. et al. Normalization of the vasculature for treatment of cancer and other diseases. Physiol. Rev. 91, 1071-1121 (2011).
5. Ebos, J. M., Lee, C. R. & Kerbel, R. S. Tumor and host-mediated pathways of resistance and disease progression in response to antiangiogenic therapy. Clin. Cancer Res. 15, 5020-5025 (2009).
6. Koch, S., Tugues, S., Li, X., Gualandi, L. & Claesson-Welsh, L. Signal transduction by vascular endothelial growth factor receptors. Biochem. J. 437, 169-183 (2011).
7. Matsumoto, T. et al. VEGF receptor-2 Y951 signaling and a role for the adapter molecule TSAd in tumor angiogenesis. EMBO J. 24, 2342-2353 (2005).
8. Sun, Z. et al. VEGFR2 induces c-Src signaling and vascular permeability in vivo via the adaptor protein TSAd. J. Exp. Med. 209, 1363-1377 (2012).
9. Takahashi, T., Yamaguchi, S., Chida, K. & Shibuya, M. A single autophosphorylation site on KDR/Flk-1 is essential for VEGF-A-dependent activation of PLC-gamma and DNA synthesis in vascular endothelial cells. EMBO J. 20, 2768-2778 (2001).
10. Sakurai, Y., Ohgimoto, K., Kataoka, Y., Yoshida, N. & Shibuya, M. Essential role of Flk-1 (VEGF receptor 2) tyrosine residue 1173 in vasculogenesis in mice. Proc. Natl Acad. Sci. USA 102, 1076-1081 (2005).
11. Valenzuela, D. M. et al. High-throughput engineering of the mouse genome coupled with high-resolution expression analysis. Nat. Biotechnol. 21, 652-659 (2003).
12. Weis, S. et al. Src blockade stabilizes a Flk/cadherin complex, reducing edema and tissue injury following myocardial infarction. J. Clin. Invest. 113, 885-894 (2004).
13. Dejana, E. & Vestweber, D. The role of VE-cadherin in vascular morphogenesis and permeability control. Prog. Mol. Biol. Transl. Sci. 116, 119-144 (2013).
14. Gerhardt, H. et al. VEGF guides angiogenic sprouting utilizing endothelial tip cell filopodia. J. Cell Biol. 161, 1163-1177 (2003).
15. Bentley, K. et al. The role of differential VE-cadherin dynamics in cell rearrangement during angiogenesis. Nat. Cell. Biol. 16, 309-321 (2014).
16. Stan, R. V. et al. The diaphragms of fenestrated endothelia: gatekeepers of vascular permeability and blood composition. Dev. Cell 23, 1203-1218 (2012).
17. Paolinelli, R., Corada, M., Orsenigo, F. & Dejana, E. The molecular basis of the blood brain barrier differentiation and maintenance. Is it still a mystery? Pharmacol. Res. 63, 165-171 (2011).
18. Maes, W. & Van Gool, S. W. Experimental immunotherapy for malignant glioma: lessons from two decades of research in the GL261 model. Cancer Immunol. Immunother. 60, 153-160 (2011).
19. Armulik, A. et al. Pericytes regulate the blood-brain barrier. Nature 468, 557-561 (2010).
20. Hanahan, D. Heritable formation of pancreatic beta-cell tumours in transgenic mice expressing recombinant insulin/simian virus 40 oncogenes. Nature 315, 115-122 (1985).
21. Anderberg, C. et al. Deficiency for endoglin in tumor vasculature weakens the endothelial barrier to metastatic dissemination. J. Exp. Med. 210, 563-579 (2013).
22. Overwijk, W. W. & Restifo, N. P. B16 as a mouse model for human melanoma. Curr. Protoc. Immunol. Chapter 20, Unit 20.1 (2001).
23. Graham, M. M. & Evans, M. L. A simple, dual tracer method for the measurement of transvascular flux of albumin into the lung. Microvasc. Res. 42, 266-279 (1991).
24. Hayashi, M. et al. VE-PTP regulates VEGFR2 activity in stalk cells to establish endothelial cell polarity and lumen formation. Nat. Commun. 4, 1672 (2013).
25. Eliceiri, B. P. et al. Selective requirement for Src kinases during VEGF-induced angiogenesis and vascular permeability. Mol. Cell 4, 915-924 (1999).
26. Di Lorenzo, A., Fernandez-Hernando, C., Cirino, G. & Sessa, W. C. Akt1 is critical for acute inflammation and histamine-mediated vascular leakage. Proc. Natl Acad. Sci. USA 106, 14552-14557 (2009).
27. Orsenigo, F. et al. Phosphorylation of VE-cadherin is modulated by haemodynamic forces and contributes to the regulation of vascular permeability in vivo. Nat. Commun. 3, 1208 (2012).
28. Koch, S. et al. NRP1 presented in trans to the endothelium arrests VEGFR2 endocytosis, preventing angiogenic signaling and tumor initiation. Dev. Cell 28, 633-646 (2014).
29. Kohn, S., Nagy, J. A., Dvorak, H. F. & Dvorak, A. M. Pathways of macromolecular tracer transport across venules and small veins. Structural basis for the hyperpermeability of tumor blood vessels. Lab. Invest. 67, 596-607 (1992).
30. Nagy, J. A., Benjamin, L., Zeng, H., Dvorak, A. M. & Dvorak, H. F. Vascular permeability, vascular hyperpermeability and angiogenesis. Angiogenesis 11, 109-119 (2008).
31. McDonald, D. M., Thurston, G. & Baluk, P. Endothelial gaps as sites for plasma leakage in inflammation. Microcirculation 6, 7-22 (1999).
32. Berse, B., Brown, L. F., Van de Water, L., Dvorak, H. F. & Senger, D. R. Vascular permeability factor (vascular endothelial growth factor) gene is expressed differentially in normal tissues, macrophages, and tumors. Mol. Biol. Cell 3, 211-220 (1992).
33. Chen, X. L. et al. VEGF-induced vascular permeability is mediated by FAK. Dev. Cell 22, 146-157 (2012).
34. Jean, C. et al. Inhibition of endothelial FAK activity prevents tumor metastasis by enhancing barrier function. J. Cell Biol. 204, 247-263 (2014).
35. Schleicher, M. et al. The Akt1-eNOS axis illustrates the specificity of kinase-substrate relationships in vivo. Sci. Signal. 2, ra41 (2009).
36. Forstermann, U. & Sessa, W. C. Nitric oxide synthases: regulation and function. Eur. Heart J. 33, 829-837 837a-837d (2012).
37. Gratton, J. P. et al. Selective inhibition of tumor microvascular permeability by cavtratin blocks tumor progression in mice. Cancer Cell 4, 31-39 (2003).
38. Manni, S., Kisko, K., Schleier, T., Missimer, J. & Ballmer-Hofer, K. Functional and structural characterization of the kinase insert and the carboxy terminal domain in VEGF receptor 2 activation. FASEB J. 28, 4914-4923 (2014).
39. Kuppers, V., Vockel, M., Nottebaum, A. F. & Vestweber, D. Phosphatases and kinases as regulators of the endothelial barrier function. Cell Tissue Res. 355, 577-586 (2014).
40. Bergers, G. & Hanahan, D. Modes of resistance to anti-angiogenic therapy. Nat. Rev. Cancer 8, 592-603 (2008).
41. Butler, T. P., Grantham, F. H. & Gullino, P. M. Bulk transfer of fluid in the interstitial compartment of mammary tumors. Cancer Res. 35, 3084-3088 (1975).
42. Gullino, P. M. & Grantham, F. H. The vascular space of growing tumors. Cancer Res. 24, 1727-1732 (1964).
43. Schulte, D. et al. Stabilizing the VE-cadherin-catenin complex blocks leukocyte extravasation and vascular permeability. EMBO J. 30, 4157-4170 (2011).
44. Mohanty, S. & Xu, L. Experimental metastasis assay. J. Vis. Exp. 42, 1942-1944 (2010).
45. Benest, A. V. et al. Angiopoietin-2 is critical for cytokine-induced vascular leakage. PLoS ONE 8, e70459 (2013).
46. Carlsson, P. O., Andersson, A. & Jansson, L. Pancreatic islet blood flow in normal and obese-hyperglycemic (ob/ob) mice. Am. J. Physiol. 271, E990-E995 (1996).
47. Jansson, L. & Hellerstrom, C. A rapid method of visualizing the pancreatic islets for studies of islet capillary blood flow using non-radioactive microspheres. Acta Physiol. Scand. 113, 371-374 (1981).
48. Lau, J. et al. Implantation site-dependent dysfunction of transplanted pancreatic islets. Diabetes 56, 1544-1550 (2007).